Karishma Shanghvi, a prominent figure in India’s pharmaceutical and education sectors, is the daughter-in-law of Dilip Shanghvi, who is India’s wealthiest pharma billionaire. Dilip Shanghvi is ...
India.com on MSN11d
Meet Indian billionaire who tops list of biggest wealth creators of 2024, not Mukesh Ambani, Gautam Adani, Azim Premji, Shiv Nadar, Narayana Murthy, his business is…As highlighted in the report, Bharti Enterprises Chairman Sunil Mittal had an exceptional year, with his net worth doubling ...
13d
Drugmaker Sun Pharma’s investment in research and development stood at ₹792 crore, for the three months ended September 30th ...
Sun Pharma Ltd. for the second-quarter ended September 30, reported a 28% growth in net profit year-on-year to ₹3,040 crore. Gross sales for the quarter at ₹13,264 crore grew 10.5% YoY. India ...
The sales for US formulations reached $517 million in Q2FY25, growing 20.3 per cent Y-o-Y, and accounting for 33 per cent of ...
"Sun has recently strengthened its specialty pipeline through an agreement with Philogen for commercialising late stage candidate Fibromun, upon approval," Dilip Shanghvi, Chairman and Managing ...
Sun Pharmaceutical Industries has reported a notable 28% increase in its consolidated net profit, amounting to Rs 3,040 crore ...
Sun Pharmaceutical Industries reported a 28% rise in net profit, reaching Rs 3,040 crore for the September quarter, driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback